A single oral dose pharmaceutical composition comprising, triple combination of entacapone, levodopa and carbidopa, or pharmaceutically acceptable salts thereof along with other pharmaceutically acceptable excipients, wherein a "substantial portion" of entacapone or pharmaceutically acceptable salts thereof is separated from mixture of levodopa and carbidopa or pharmaceutically acceptable salts thereof.